WHO: Report from the First Consultation of the Health and Social Protection Action Research & Knowledge Sharing (SPARKS) Networks.

WHO: Digital Health for the End TB Strategy: Progress Since 2015 and Future Perspectives.

WHO: Guidelines for Treatment of Drug-Susceptible Tuberculosis and Patient Care (2017 Update).

WHO: Ethics Guidance for the Implementation of the End TB Strategy.

WHO, UNICEF: Statement on the Use of Child-Friendly Fixed-Dose Combinations for the Treatment of TB in Children.

WHO: Chest Radiography in Tuberculosis Detection Summary of Current WHO Recommendations and Guidance on Programmatic Approaches.

WHO: The Use of Delamanid in the Treatment of Multidrug-Resistant Tuberculosis in Children and Adolescents: Interim Policy Guidance.

WHO: Framework of Indicators and Targets for Laboratory Strengthening Under the End TB Strategy.

WHO: The Ue of Molecular Line Probe Assays for the Detection of Resistance to Isoniazid and Rifampicin.

WHO: A Toolkit for Developing A National TB Research Plan, in Support of the Third Pillar of the End TB Strategy.

WHO: The Use of Loop-Mediated Isothermal Amplification (TB-LAMP) for the Diagnosis of Pulmonary Tuberculosis: Policy Guidance.

WHO: Target Regimen Profiles for TB Treatment.

WHO: The Use of Molecular Line Probe Assays for the Detection of Resistance to Second-Line Anti-Tuberculosis Drugs.- Policy Guidance.

WHO: Report on the WHO/TDR Consultation on Promoting Implementation/Operational Research in Countries Receiving Grants from the Global Fund to Fight AIDS, Tuberculosis and Malaria.

WHO: Implementing the End TB Strategy: The Essentials.

WHO: Integrating Collaborative TB and HIV Services within a Comprehensive Package of Care for People Who Inject Drugs.

WHO: Report of the Global Consultation on the Programmatic Management of Latent Tuberculosis Infection.

WHO: Report of a WHO Consultation Meeting to Enhance the Engagement of Communities, Nongovernmental and Other Civil Society Organizations in Implementing the End TB Strategy.

WHO: On the Road to Ending TB: Highlights from the 30 Highest TB Burden Countries.

WHO: Promoting Access, Quality and Innovation to Save and Improve Lives.

WHO: Global Tuberculosis Report 2016.

WHO: A Global Action Framework for TB Research in Support of the Third Pillar of WHO’s End TB Strategy.

WHO: Systematic Screening for Active Tuberculosis: An Operational Guide.

WHO: Active Tuberculosis Drug-Safety Monitoring and Management (aDSM): Framework for Implementation.

WHO: Guidelines on the Management of Latent Tuberculosis Infection.

WHO: The Use of Lateral Flow Urine Lipoarabinomannan Assay (LF-LAM) for the Diagnosis and Screening of Active Tuberculosis in People Living with HIV.

WHO: Digital Health for the End TB Strategy - An Agenda for Action.

WHO: A Guide to Monitoring and Evaluation for Collaborative TB/HIV Activities.

WHO: Implementing Tuberculosis Diagnostics: A Policy Framework.

WHO: A Situation Assessment Tool to Engage All Relevant Care Providers in Drug-Resistant Tuberculosis (DR-TB) Management at Country Level.

WHO: Recommendation on 36 Months Isoniazid Preventive Therapy to Adults and Adolescents Living with HIV in Resource-Constrained and High TB and HIV-Prevalence Settings: 2015 Update.

WHO: Framework for the Engagement of All Health Care Providers in the Management of Drug Resistant Tuberculosis.

WHO: Best Practices in Engagement of All Health Care Providers in the Management of Drug Resistant Tuberculosis.

WHO: Accelerating Progress on HIV, Tuberculosis, Malaria, Hepatitis and Neglected Tropical Diseases.

WHO: Scaling up of Collaborative TB/HIV Activities in Concentrated HIV Epidemic Settings.

WHO: Determination of Fabric Strength of Long-Lasting Insecticidal Nets.

WHO: Global Tuberculosis Report 2015.

WHO: Companion Handbook to the WHO Guidelines for the Programmatic Management of Drug-Resistant Tuberculosis.

WHO: Understanding and Using Tuberculosis Data.

WHO: Framework Towards Tuberculosis Elimination in Low-Incidence Countries.

WHO: ENGAGE-TB Approach: Training Manual.

WHO: Standards and Benchmarks for Tuberculosis Surveillance and Vital Registration Systems.

WHO: A Guide for Tuberculosis Patients to Quit Smoking.

WHO: International Standards for Tuberculosis Care. 3rd Edition.

WHO: Guidance for National Tuberculosis Programmes on the Management of Tuberculosis in Children 2nd Edition.

WHO: Xpert MTB/RIF Assay for the Diagnosis of Pulmonary and Extrapulmonary TB in Adults and Children.

WHO: Childhood TB.

WHO: Framework for Conducting Reviews of Tuberculosis Programmes.

WHO: High-Priority Target Product Profiles for New Tuberculosis Diagnostics.

WHO: Toolkit for Delivering the 5A’s and 5R’s Brief Tobacco Interventions to TB Patients in Primary Care.

WHO: Policy Implementation Package for New TB Drug Introduction.

WHO: The Use of Delamanid in the Treatment of Multidrug-Resistant Tuberculosis.

WHO: Management of Drug-Resistant Tuberculosis: Training for Staff Working at DR-TB Management Centres.

WHO: Caring for the Sick Child in the Community, Adaptation for High HIV or TB Settings.

WHO: Xpert MTB/RIF Implementation Manual.

WHO: Management of Tuberculosis.

WHO: Global Tuberculosis Report 2014.

WHO: Philippines PMDT Review Mission Report 2014.

WHO: On the Road to Ending TB: Highlights from the 30 Highest TB Burden Countries.

WHO: Promoting Access, Quality and Innovation to Save and Improve Lives.

WHO: Gear Up to End TB.

WHO: Introducing the WHO End TB Strategy.

WHO: Reaching People with Multidrug-Resistant TB Brochure.

WHO: Reach the 3 million: Find. Treat. Cure TB.

WHO: WHO Global Task Force on TB Impact Measurement.

WHO: First Meeting of the Global GLC Committee.

WHO: Third Global GLC meeting.

WHO: WHO Strategic and Technical Advisory Group for Tuberculosis (STAG-TB).

WHO: Second Global GLC Committee Meeting.

WHO: WHO Strategic and Technical Advisory Group for Tuberculosis (STAG-TB).

WHO: Report of a WHO Consultation on Strengthening the Active Engagement of Civil Society Organizations in the Global TB Prevention, Care and Control Efforts.